The 5 Highest-Priced Drugs: BioMarin Pharmaceutical Inc.'s $380,000 Latest Is Not Even Close To Top

Published: Feb 20, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BioMarin Pharmaceutical Inc. priced its latest rare disease drug Tuesday at $380,000 a year. But the most interesting thing about the price of Vimizim, the San Rafael-based drug developer's recently approved enzyme replacement therapy for people with Morquio A syndrome, is that BioMarin isn't even close to being No. 1. In fact, Vimizim would have to raise its price by more than $35,000 even to reach second place.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news